INTRODUCTION
STUDY GOALS AND OBJECTIVES
- To define and intensively analyze the global biotechnology equipment market
- To analyze comprehensively each market segment with respect to market drivers, restraints and opportunities that are affecting market revenues and trends
- To quantify market size, in revenues, for the overall market and each market segment with respect to technology and revenues attributed to respective geographies (North America, Europe, Asia and Rest of the World)
- To analyze and comprehend the core competency of the market players by profiling companies with respect to their product offerings specific to the biotechnology equipment, market specific strategies and recent developments.
REASONS FOR DOING THE STUDY
The trial-and-error-based drug market is evolving into more development based on scientific evidence. Stringent laws and regulations are pressuring market players to invest in high-end technologies enabling speedy commercialization of new drugs. A pharmaceutical-to-biotechnology transition in the industry is further complicating the market environment. Complex factors are significantly driving the biotechnology equipment market. In this scenario, it becomes essential for stakeholders in the analytical instruments market, who were dominantly targeting the chemical industry in the past, to understand the business environment in biotechnology to tap the fastest growing markets.
The biotechnology market is highly promising due to continuous innovations and transitions, such as the transition from genomics to proteomics, and moving forward to systems biology. Such quick transition compels the market players to understand market needs in order to appropriately position their products. Furthermore, the competition is severe and, with less room for product differentiation, it becomes essential for the competitors to focus exclusively on the biotechnology industry.
SCOPE AND FORMAT
The report categorizes the global biotechnology equipment market as follows:
TECHNOLOGY MARKET
This market includes: chromatography, electrophoresis, sequencers and synthesizers, laboratory automation, an array market, immunoassay, imaging, mass spectrometry and others.
END-USER APPLICATION MARKET
This market includes biopharmaceuticals, academic institutions, government, agriculture, food and beverages, environmental testing labs, gene/protein expression, toxicogenomics, toxicoproteomics, pharmacogenomics, pharmacopro-teomics, HTS screening, life science and clinical imaging and others).
APPLICATION MARKET—DIAGONOSIS AND DRUG DISCOVERY
This market includes drug development, target validation, ADME TOX profiling, target identification, biomarker discovery, proteomics and genomics.
The report also analyzes micro markets such as data systems, mobile phase reservoirs, detectors, auto samplers, and columns with substantial analytical content and market estimations. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic sections with respect to the competitive landscape and market overview. The report will encompass more than 40 company profiles.
METHODOLOGY
The market engineering model to be considered for biotechnology equipment has been challenging as equipment for chromatography, mass spectrometry, laboratory automation, imaging, etc., is being intensively used in other applications, such as in chemical laboratories, hospitals etc. The penetration levels specifically for biotechnology have been considered, keeping in mind the scope of primary and secondary data collected. Some other aspects of the methodology are given below:
- Biotechnology forms an integral part of industries such as food, pharmaceuticals, agriculture, and environmental laboratories. Moreover, other noncommercial applications of biotechnology are also included; they are government (also includes biotech applications in defense) and academic institutions.
- Biotechnology equipment is popularly used in drug discovery and finds major applications with 50% penetration. However, it also has applications in diagnosis in areas such as blood processing, blood grouping and typing, drug-of-abuse testing, hormone-level testing, drug monitoring, etc., with a 35% penetration level. Other applications include identification of bioterrorism agents in defense and basic research.
- Chromatography has the widest application in life sciences with around 50% penetration. Approximately 40% of the total chromatography market is considered to be in biotechnology. Apart from biotechnology, it is applied throughout the chemical industry.
- Electrophoresis is used for separation and purification of biomolecules. Therefore, it finds major applications in biotechnology with 85% penetration.
- Sequencers and synthesizers, immunoassays and arrays, have prime applications in biotechnology with 100% penetration.
- Mass spectrometry is largely used in chemical industries. Due to fewer applications in biotechnology, it is considered to be less than 15% of the entire mass spectrometry market.
- Imaging equipment is commonly used in hospitals for diagnosis. In biotechnology, imaging equipment is used for drug monitoring, structural analysis, etc. However, imaging equipment in biotechnology forms a very small market, less than 10% of the entire imaging market.
- Laboratory automation equipment is widely used in several industries other than biotechnology; they include information technology (IT), the automobile industry, the chemical industry, etc. Biotechnology, therefore, forms a small part of such a broad range of industries. The market for laboratory automation in biotechnology is considered to be around 7% of the total laboratory automation market.
INTENDED AUDIENCES
The intended audience includes professionals in:
- Pharmaceutical and biotechnology companies
- Analytical instrument manufacturers, distributors and suppliers
- Pharmaceutical and biotechnology associations
- Contract research organizations.
INFORMATION SOURCES
Market data consists of aggregate sales figures of submarkets within biotechnological equipment applications. We analyze most of the new technology and product launches in the biotechnological equipment market. We have researched all the technology patents over the last 5 years. Secondary research progressed through both paid and unpaid sources. Primary research was conducted to provide more understanding of the biotechnology equipment industry.
ANALYST CREDENTIALS
Sathya Durga has more than 4 years of domain experience. Apart from research and consulting, she has conducted analyst briefings for the top players in a wide range of market segments. She has been quoted in popular Web sites such as rfidjournal.com, livewire.com, 2012 predictions.net, and others. After earning her MBA (marketing and finance stream) from Chennai University, she worked with Frost & Sullivan and BOC.
Sathya Durga has authored several market research studies in the healthcare domain. The subjects include:
- Global weight management market
- Tele-medicines: a mainstream technology
- High-growth markets in healthcare and life sciences
- Carbonated soft drinks market.
- Adoption rates and analysis of OTC diabetic medicines and supplements
- Radio frequency identification (RFID), real time locating systems (RTLS), IP surveillance and other emerging technologies in the healthcare domain.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Report Code: BIO070A, Published: January 2010, Analyst: Sathya Durga
